Nordic Nanovector ASA announced the appointment of Dr. Mark Wright as Head of Manufacturing. He joins the company on January 2, 2019 and will lead all aspects of the manufacture of Betalutin® for clinical trials and future commercialisation, as well as the production of new CD37-targeting candidates emerging from the company's pipeline. Dr. Wright joins from Piramal Healthcare.